BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 25359698)

  • 1. Point-of-care testing for haemoglobin A1c in remote Australian Indigenous communities improves timeliness of diabetes care.
    Spaeth BA; Shephard MD; Schatz S
    Rural Remote Health; 2014; 14(4):2849. PubMed ID: 25359698
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The impact of point of care testing on diabetes services along Victoria's Mallee Track: results of a community-based diabetes risk assessment and management program.
    Shephard MD; Mazzachi BC; Shephard AK; McLaughlin KJ; Denner B; Barnes G
    Rural Remote Health; 2005; 5(3):371. PubMed ID: 16026194
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diabetes care in remote northern Australian Indigenous communities.
    McDermott RA; Tulip F; Schmidt B
    Med J Aust; 2004 May; 180(10):512-6. PubMed ID: 15139828
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Results from 15years of quality surveillance for a National Indigenous Point-of-Care Testing Program for diabetes.
    Shephard M; Shephard A; McAteer B; Regnier T; Barancek K
    Clin Biochem; 2017 Dec; 50(18):1159-1163. PubMed ID: 28734906
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of a training program for device operators in the Australian Government's Point of Care Testing in General Practice Trial: issues and implications for rural and remote practices.
    Shephard MD; Mazzachi BC; Watkinson L; Shephard AK; Laurence C; Gialamas A; Bubner T
    Rural Remote Health; 2009; 9(3):1189. PubMed ID: 19689171
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sustaining better diabetes care in remote indigenous Australian communities.
    McDermott R; Tulip F; Sinha A
    Qual Saf Health Care; 2004 Aug; 13(4):295-8. PubMed ID: 15289633
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Review of the cultural safety of a national Indigenous point-of-care testing program for diabetes management.
    Shephard M; O'Brien C; Burgoyne A; Croft J; Garlett T; Barancek K; Halls H; McAteer B; Motta L; Shephard A
    Aust J Prim Health; 2016; 22(4):368-374. PubMed ID: 26330366
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Point-of-care testing of HbA1c, renal function and lipids in remote or disadvantaged regions.
    Handrinos L; Januszewski AS; Trimble E; Donelan N; Williams P; Jenkins AJ
    Intern Med J; 2020 Dec; 50(12):1567-1571. PubMed ID: 33354871
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cultural and clinical effectiveness of the 'QAAMS' point-of-care testing model for diabetes management in Australian aboriginal medical services.
    Shephard MD
    Clin Biochem Rev; 2006 Aug; 27(3):161-70. PubMed ID: 17268584
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sustaining better diabetes care in remote indigenous Australian communities.
    McDermott R; Tulip F; Schmidt B; Sinha A
    BMJ; 2003 Aug; 327(7412):428-30. PubMed ID: 12933731
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Using glycated haemoglobin testing to simplify diabetes screening in remote Aboriginal Australian health care settings.
    Marley JV; Oh MS; Hadgraft NT; Singleton SL; Isaacs K; Atkinson DN
    Med J Aust; 2015 Jul; 203(1):28-32. PubMed ID: 26126564
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Strengthening health promotion development with Aboriginal and Torres Strait Islander males in remote Australia: A Northern Territory perspective.
    Souter J; Smith JA; Canuto K; Gupta H
    Aust J Rural Health; 2022 Aug; 30(4):540-543. PubMed ID: 35596642
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diabetes in the Torres Strait Islands of Australia: better clinical systems but significant increase in weight and other risk conditions among adults, 1999-2005.
    McDermott RA; McCulloch BG; Campbell SK; Young DM
    Med J Aust; 2007 May; 186(10):505-8. PubMed ID: 17516896
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design, implementation and initial assessment of the Northern Territory Point-of-Care Testing Program.
    Shephard MD; Spaeth B; Mazzachi BC; Auld M; Schatz S; Loudon J; Rigby J; Daniel V
    Aust J Rural Health; 2012 Feb; 20(1):16-21. PubMed ID: 22250872
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A multifaceted health-service intervention in remote Aboriginal communities: 3-year follow-up of the impact on diabetes care.
    Bailie RS; Si D; Robinson GW; Togni SJ; D'Abbs PH
    Med J Aust; 2004 Aug; 181(4):195-200. PubMed ID: 15310253
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Implementation of POCT in the diabetic clinic in a large hospital.
    Tanyanyiwa D; Dandara C; Bhana SA; Pauly B; Marule F; Ramokoka M; Bwititi P; Nwose U; Nkosi B
    Afr Health Sci; 2015 Sep; 15(3):902-7. PubMed ID: 26957980
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Impact of Point-of-Care Hemoglobin A1c Testing on Population Health-Based Onsite Testing Adherence: A Primary-Care Quality Improvement Study.
    Crocker JB; Lynch SH; Guarino AJ; Lewandrowski K
    J Diabetes Sci Technol; 2021 May; 15(3):561-567. PubMed ID: 33233954
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Point-of-care testing improves diabetes management in a primary care clinic in South Africa.
    Motta LA; Shephard MDS; Brink J; Lawson S; Rheeder P
    Prim Care Diabetes; 2017 Jun; 11(3):248-253. PubMed ID: 28161128
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effectiveness of point-of-care testing for therapeutic control of chronic conditions: results from the PoCT in General Practice Trial.
    Bubner TK; Laurence CO; Gialamas A; Yelland LN; Ryan P; Willson KJ; Tideman P; Worley P; Beilby JJ
    Med J Aust; 2009 Jun; 190(11):624-6. PubMed ID: 19485840
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Variation between Point-of-care and Laboratory HbA1c testing in Clinical Practice.
    Fellows SE; Cipriano GC
    P R Health Sci J; 2019 Sep; 38(3):189-191. PubMed ID: 31536634
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.